With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Guns are now the leading cause of death for children in the US May 27, 2022
- Defaults The number of young people seeking help for payment difficulties has clearly increased, says the Guarantee Foundation Sep 7, 2021
- Neither Derbez nor Ruffo, what is José Eduardo’s real name? Oct 7, 2020
- Graz Museum shows exhibition by the “Blade Runner” designer Dec 8, 2020
- Côtes-d’Armor: Member of a religious group, a 72-year-old man convicted of sexual assault Nov 25, 2022
- Gisela Valcárcel: her misogynistic comment prior to the presentation of Korina Rivadeneira Aug 29, 2021
- Protests in Iran: More than 70 dead in one week, says NGO Nov 23, 2022